TME PHARMA NV (ALTME.PA) Stock Price, Quote, News and Overview

What is the stock price of TME PHARMA NV today?

The current stock price of ALTME.PA is 0.0702 EUR. The price decreased by -2.9% in the last trading session.

What is the ticker symbol for TME PHARMA NV stock?

The exchange symbol of TME PHARMA NV is ALTME and it is listed on the Euronext Paris - Matif exchange.

On which exchange is ALTME.PA stock listed?

ALTME.PA stock is listed on the Euronext Paris - Matif exchange.

What is the price forecast or stock price prediction for TME PHARMA NV stock?

10 analysts have analysed ALTME.PA and the average price target is 0.4 EUR. This implies a price increase of 466.67% is expected in the next year compared to the current price of 0.0702. Check the TME PHARMA NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is TME PHARMA NV worth?

TME PHARMA NV (ALTME.PA) has a market capitalization of 6.61M EUR. This makes ALTME.PA a Nano Cap stock.

How many employees does TME PHARMA NV have?

TME PHARMA NV (ALTME.PA) currently has 13 employees.

What are the support and resistance levels for TME PHARMA NV (ALTME.PA) stock?

TME PHARMA NV (ALTME.PA) has a support level at 0.07 and a resistance level at 0.07. Check the full technical report for a detailed analysis of ALTME.PA support and resistance levels.

Should I buy TME PHARMA NV (ALTME.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of ALTME.PA, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of ALTME.PA, evaluating the profitability, health, valuation and growth aspects
• TME PHARMA NV (ALTME.PA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• TME PHARMA NV (ALTME.PA) Sales and EPS estimates to see what analysts future expectations are.
• TME PHARMA NV (ALTME.PA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• TME PHARMA NV (ALTME.PA) Insider and Institutional Ownership to learn about the owners and their transactions.
• TME PHARMA NV (ALTME.PA) Stock Chart to make your own analysis
• TME PHARMA NV (ALTME.PA) Latest news and press-releases to stay up to date.

Does TME PHARMA NV (ALTME.PA) stock pay dividends?

ALTME.PA does not pay a dividend.

What is the Price/Earnings (PE) ratio of TME PHARMA NV (ALTME.PA)?

TME PHARMA NV (ALTME.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.58).

ChartMill assigns a fundamental rating of 2 / 10 to ALTME.PA. The financial health of ALTME.PA is average, but there are quite some concerns on its profitability.

Over the last trailing twelve months ALTME.PA reported a non-GAAP Earnings per Share(EPS) of -0.58. The EPS increased by 86.82% compared to the year before.

ChartMill assigns a Buy % Consensus number of 86% to ALTME.PA. The Buy consensus is the average rating of analysts ratings from 10 analysts.